What is the present valuation and projected CAGR of the implantable neurostimulation devices market?
The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $8.68 $ billion in 2024 to $9.64 $ billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to increasing demand for non-pharmacological treatments, growing demand for minimally invasive procedures, growing geriatric population, increasing the wide range of psychiatric disorders, and increasing incidence of chronic diseases.
The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $14.53 $ billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising prevalence of neurological disorders, rise in prevalence of lifestyle diseases, rising awareness, increase in spinal cord injuries, and increasing healthcare expenditure. Major trends in the forecast period include sensing technology, increasing advances in neurostimulation technologies, technologically advanced products, incorporating closed-loop systems, and integrating wireless technology.
Get Your Free Sample of The Global Implantable Neurostimulation Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp
What key drivers have fueled the implantable neurostimulation devices market’s development over the years?
The rising prevalence of neurological disorders is expected to propel the growth of the implantable neurostimulation device market going forward. A neurological disorder is any condition that affects the structure or function of the nervous system, resulting in various symptoms such as paralysis, seizures, and cognitive impairments. The increased exposure to risk factors such as high blood pressure, developmental abnormalities, trauma or injury leads to higher detection rates of neurological disorders. Implantable neurostimulation devices are used for neurological disorders to modulate nerve activity and alleviate symptoms when other treatments are ineffective or insufficient. For instance, in 2024, according to the Alzheimer’s Association, a US-based non-profit voluntary health organization, an estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s disease, with 73% being age 75 or older. This number is projected to grow to 12.7 million by 2050. Therefore, the rising prevalence of neurological disorders will drive the implantable neurostimulation device market.
What is the segmentation for the implantable neurostimulation devices market?
The implantable neurostimulation devicesmarket covered in this report is segmented –
1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types
2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices
2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators
3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders
4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence
5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression
6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies
Order your report now for swift delivery
Who are the most influential companies in the implantable neurostimulation devices market?
Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC
What are the top industry trends projected to impact the implantable neurostimulation devices market?
Major companies operating in the implantable neurostimulation devices market are focused on developing technologically advanced products, such as spinal cord stimulation (SCS) systems, to relieve chronic pain conditions. A spinal cord stimulation (SCS) system is a medical device that uses electrical impulses to modulate nerve activity in the spinal cord to alleviate chronic pain and improve the quality of life for patients when other treatments are ineffective. For instance, in December 2022, Abbott, a US-based medical device company, announced the U.S. Food and Drug Administration (FDA) approval for the Eterna spinal cord stimulation (SCS) system. The Eterna SCS is the market’s smallest implantable, rechargeable spinal cord stimulator, engineered for maximum daily comfort. It features Abbott’s proprietary BurstDR stimulation technology, which mimics natural brain firing patterns for superior pain relief and is preferred by 87% of patients over traditional tingling stimulation. With the lowest recharging needs, requiring as few as five recharges annually due to Xtend energy technology, Eterna ensures convenience. It supports full-body MRI scans with TotalScan technology and is adaptable to future advancements without replacement. Abbott’s mobile app integration also enables real-time tracking of battery life and charging status on iPhone devices.
What are the major regional insights for the implantable neurostimulation devices market, and which region holds the top position?
North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Implantable Neurostimulation Devices Market Report 2025 Offer?
The implantable neurostimulation devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body and are used to modulate nerve activity. The devices represent a sophisticated approach to managing conditions that may not respond well to medication alone, offering patients a chance to improve their quality of life.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19520
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
